Related Experiment Video
Updated: Dec 27, 2025
11:22
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
30.9K
Gut microbiota and metabolic syndrome
Peng-Xu Wang1, Xin-Ru Deng1, Chen-Hong Zhang2
1Department of Endocrinology, Henan University People's Hospital; Henan Provincial People's Hospital, Zhengzhou, Henan 450003, China.
Chinese Medical Journal
|February 28, 2020
Summary
Metabolic syndrome (MetS) is linked to gut bacteria changes, with harmful bacteria increasing and beneficial ones decreasing. Further human studies are needed to confirm and utilize these gut microbiota links for MetS prevention and treatment.
Area of Science:
- Microbiology
- Human Metabolism
- Disease Mechanisms
Background:
- Metabolic syndrome (MetS) is a cluster of risk factors for cardiovascular and cerebrovascular diseases.
- Understanding MetS mechanisms is crucial for developing effective prevention and intervention strategies.
- Gut microbiota alterations are implicated in MetS pathogenesis.
Purpose of the Study:
- To discuss the relationship between clinical symptoms of MetS and gut microbial community differences.
- To explore the mechanisms mediating gut microbiota and host metabolism interactions.
- To highlight the need for further clinical research on gut microbiota in MetS.
Main Methods:
- Review of existing literature on MetS and gut microbiota.
- Comparison of gut microbial profiles in MetS patients versus healthy individuals.
- Discussion of potential mediating factors like inflammation, SCFAs, and bile acids.
Main Results:
- MetS is characterized by an imbalance in gut microbiota, favoring potentially harmful bacteria over beneficial ones.
- Gut barrier defects, short-chain fatty acids, and bile acid metabolism are key interaction points.
- Causal relationships are established in animal models but remain controversial in humans.
Conclusions:
- Gut microbiota plays a significant role in the development of MetS.
- Further clinical studies are essential to confirm these findings in humans.
- Targeting gut microbiota manipulation holds potential for MetS prevention and treatment.
Related Concept Videos
01:17Irritable Bowel Syndrome I: Introduction
850
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
850
01:23Anatomy of the Intestines
86.3K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
86.3K
01:50What is Monogastric Digestion?
74.8K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
74.8K
01:29Bacterial Flora of the Large Intestine
1.4K
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.4K
01:24Overview of Lipid Metabolism
4.6K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.6K
01:19Overview of Carbohydrate Metabolism
3.0K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.0K